Estimate Recalculated Nov 7, 2024 05:11PM EST
ALTA BIOPHARMA PARTNERS III LP has an estimated net worth of $6.42 Million. This is based on reported shares across multiple companies, which include COTHERIX INC, NeurogesX Inc, Cara Therapeutics, Inc., CymaBay Therapeutics, Inc., MACROGENICS INC, CHIMERIX INC, THRESHOLD PHARMACEUTICALS INC, SUNESIS PHARMACEUTICALS INC, TorreyPines Therapeutics, Inc., and Aegerion Pharmaceuticals, Inc..
ALTA BIOPHARMA PARTNERS III LP's CIK is 0001257444
2009 was ALTA BIOPHARMA PARTNERS III LP's most active year for acquiring shares with 4 total transactions. ALTA BIOPHARMA PARTNERS III LP's most active month to acquire stocks was the month of September. 2007 was ALTA BIOPHARMA PARTNERS III LP's most active year for disposing of shares, totalling 6 transactions. ALTA BIOPHARMA PARTNERS III LP's most active month to dispose stocks was the month of December. 2010 saw ALTA BIOPHARMA PARTNERS III LP paying a total of $3,000,413.90 for 15,487,876 shares, this is the most they've acquired in one year. In 2009 ALTA BIOPHARMA PARTNERS III LP cashed out on 2,044,750 shares for a total of $4,108,720.65, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!